Rheumatology Therapeutics Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
The global rheumatology therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). The growth of the rheumatology therapeutics market is primarily driven by the increased utilization of disease-modifying anti-rheumatic medicines (DMARDs) for targeted disease treatment. Recent steps in rheumatology have led to a diverse range of drug options available to rheumatologists, particularly for managing rheumatic joint disorders. The World Health Organization (WHO) reported that around 18 million individuals were living with rheumatoid arthritis globally in 2019. This condition predominantly affects women (70%) and those aged over 55 (55%).One such condition, Polymyalgia rheumatica, can severely impair daily activities due to its flares of painful symptoms across multiple body areas an approval by the FDA for a steroid-free treatment for polymyalgia rheumatica marks a significant step in treatment. For instance, in March 2023, for sarilumab (Kevzara), an interleukin (IL) 6 receptor antagonist, gained FDA approval for individuals with polymyalgia rheumatica who have either failed glucocorticoid treatment or cannot tolerate its tapering.
Often, patients with psoriatic arthritis are not able not suspect a connection between their psoriasis skin symptoms and the joint pain, swelling and stiffness, resulting in delayed diagnosis and treatment. For instance, in January 2022, AbbVie released FDA-approved SKYRIZI® (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), a systemic inflammatory disease that affects the skin and joints and impacts approximately 30% of patients with psoriasis. Ankylosing spondylitis (AS) is a chronic, inflammatory disease of the axial spine. Chronic back pain and progressive spinal stiffness are the most common features of this disease. For instance, in November 2021, Pfizer Inc. announced that the European Commission has approved XELJANZ® (tofacitinib) 5 mg twice daily for the treatment of adults with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy.
To Request a Sample of our Report on Rheumatology Therapeutics Market : https://www.omrglobal.com/request-sample/rheumatology-therapeutics-market
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
Segment Covered-
· By Drug Type
· By Disease Indication
· By Category
· By Distribution Channel
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape- includes Merck & Co., Inc., Novartis AG, Pfizer Inc. and others.
A full Report of Rheumatology Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/rheumatology-therapeutics-market
Rheumatology Therapeutics Market Report Segment
By Drug Type
• Disease-modifying Anti-rheumatic Drugs
• Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Uric Acid Drugs
• Others
By Disease Indication
• Rheumatoid Arthritis
• Osteoarthritis
• Gout
• Psoriatic Arthritis
• Ankylosing Spondylitis
By Category
• Prescription
• Over-the-Counter (OTC)
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Rheumatology Therapeutics Market Report Segment by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
• Latin America
• Middle East and Africa
Company Profiles
· AbbVie Inc.
· Amgen Inc.
· AstraZeneca plc
· Aurinia Pharmaceuticals Inc.
· Boehringer Ingelheim International GmbH
· Bristol-Myers Squibb Co.
· Eli Lilly
· F. Hoffmann-La Roche Ltd.
· Gilead Sciences, Inc.
· Janssen Pharmaceuticals, Inc.
· Johnson & Johnson Private Ltd.
· Regeneron Pharmaceuticals Inc.
· Sanofi, Genentech, Inc.
· Takeda Pharmaceutical Company Ltd.
· UCB S.A.
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/rheumatology-therapeutics-market
https://www.somosxbox.com.mx/noticias-urgente/tasa-de-crecimiento-lento-del-mercado-de-vacunas-de-vectores-recombinantes-prevista-para-2023-2030/119327/
https://perualdia.net/el-mercado-de-gestion-de-trafico-sera-testigo-de-la-aceleracion-del-crecimiento-para-2028/
https://ekz-crosstour.ch/news/nordamerikanische-marktanalyse-fuer-elektrogehaeuse-groesse-aktuelles-szenario-und-zukunftsaussichten/122952/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rheumatology Therapeutics Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029) here
News-ID: 3214614 • Views: …
More Releases from Orion Market Research
Women Active Wear Market is Dazzling Worldwide and Forecast to 2031
Women activewear market is anticipated to grow at a significant CAGR during the forecast period. Activewear is a type of apparel that is worn by athletes who participate in sports and fitness activities. It has multiple advantages, including increased grip, wicking function, and bi-stretchable properties, which assist athletes to improve their performance.
Activewear's numerous and unique benefits, such as breathability, quick-drying, static resistance, thermal resistance, and chemical resistance, are driving the…
Pilates and Yoga Studios Market to Witness Growth Acceleration by 2031/ Alona Pi …
The global pilates and yoga studios market is anticipated to grow at a considerable CAGR of 9.6% during the forecast period. The global pilates and yoga studios market is witnessing rapid growth due to growing awareness regarding the benefits offered by pilates and yoga. Pilates improves the body posture and flexibility, increases muscle strength, tones the muscles, and provides relaxation to body muscles. All these benefits are estimated to drive the growth…
Home Gym Equipment Market is Likely to Increase at a Significantly High CAGR dur …
The global home gym equipment market is growing at a CAGR of 3.2% during the forecast period. The home gym equipment market is one of the fastest-growing industries at present owing to the COVID-19 outbreak, as many gyms and health clubs were under lockdown since Q1 2020. Hence, the consumer's shift toward home gym was a positive driving factor for the home gym equipment industry. Home gym equipment is also…
Hiking Gear and Equipment Market Outlook 2024-2031: Trends and Opportunities/ Ad …
Hiking Gear and Equipment Market is anticipated to register a significant growth of 4.3% during the forecast period. The primary attribute promoting the growth of the hiking gear and equipment market is the boost in sporting activities among the youths. The prominence of outdoor sporting events has been increasing gradually over the years due to fitness trends, healthy lifestyles, and recreational activities. This trend in opting fit and healthy lifestyle…
More Releases for Rheumatology
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty
December 05-06, 2022 | Dubai, UAE
Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty
Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc.
Audience Profile:
· …
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology…
Increasing burden of rheumatology diseases globally is propelling the growth of …
Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to…
Rheumatology Therapeutics Market-Technological Breakthroughs by 2025
heumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to…
Rheumatology Therapeutics Market: Burgeoning Elderly Population Drives Growth
Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. Some other key players in the market are Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025…
Global Rheumatology Market to 2024
Global rheumatology market was valued at $31bn in 2015 and is forecast to grow at a modest 4.0% CAGR between 2015 and 2024 to reach 2024 global sales of $46bn.
http://optimainsights.org/request-toc/global-rheumatology-market-to-2024
Rheumatology encompasses numerous musculoskeletal and autoimmune diseases that cause systemic manifestations including joint pain, inflammation and destruction. Worldwide, over 470 million people suffer from rheumatologic diseases. Rheumatology represents a significant disease burden with annual costs associated with rheumatologic diseases estimated at…